(President: Shigeo Nakamura, Headquarters: Chuo-ku, Tokyo, hereinafter referred to as "Ajinomoto") has been conducting joint ...

A new study published in the journal Alzheimer’s & Dementia reports that a novel vaccine targeting a toxic form of the tau ...

Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

OBI Pharma has received clearance from the US FDA for an IND application for OBI-902 to begin a Phase I/II trial for advanced ...

Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease.